Results Snapshot
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 106.92% vs 84.81% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is 2.90% vs -18.58% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Panacea Biotec With
Nine Monthly - Net Sales
YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023
Nine Monthly - Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
YoY Growth in nine months ended Dec 2024 is 106.92% vs 84.81% in Dec 2023
Nine Monthly - Interest
YoY Growth in nine months ended Dec 2024 is 2.90% vs -18.58% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023